Chipotle Just Reported Earnings & One Trader Says The Stock Is Approaching An “Incredibly Bullish” Level

After Chipotle’s earnings beat, one trader says the stock could surge to new highs if it can break above this key level.

Chipotle (NYSE: CMG) delivered an earnings beat on Wednesday, smashing expectations as online sales overtook in-person orders for the first time.

The fast-casual chain posted adjusted earnings per share of $5.26, versus estimates for earnings of $4.89 per share, on revenue of $1.74 billion. Digital sales rose 134% in the quarter, while same-store sales grew 17.2%.

One thing that drove the surge in online sales was Chipotle’s new quesadilla, which CEO Brian Niccol said was ordered by 1-in-10 customers, helping the company see its highest number of new customers in March.

“We made sure we took the proper time to develop an excellent product that customers love,” Niccol said of the new quesadilla, adding that the digital-only item is creating a new eating occasion, like a mid-afternoon snack.

Looking ahead, Chipotle said it predicts second quarter comparable sales to be in the high-20% to 30% range.

Despite all that good news, the stock is down 4% for the week, which could be an opportunity for investors.

Miller Tabak chief market strategist Matt Maley argues that strength of Chipotle’s earnings could carry it to new highs.

“We’re looking at this $1,550 level,” Maley said. “That was the old high back in February.”

As of this writing, the stock is just 4.5% below the $1,550 level Maley is watching for.

“If it can break above that kind of double-top high in any kind of meaningful fashion,” Maley said, “it’s going to be incredibly bullish for the stock on a technical basis, so, you’ll definitely want to continue to buy the stock.”

Source: TradingView.
 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More